Björn Cochlovius, Ph.D., is a Molecular Biologist and Associate Professor for Immunology at Heidelberg University, Heidelberg, Germany.
- Dr. Cochlovius has held various leadership positions in biotech (e.g., Affitech, Oslo) and big pharma (amongst others at Roche, Basel; Abbvie, Singapore) in R&D, Business Development & Licensing and strategic positions.
- He currently holds two chairmanships (Sapreme, Netherlands, and Karolinska Development, Sweden).
